MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced its rebranding to Terumo Neuro, effective imme ...

The European Society of Cardiology (ESC) recently announced the publication of the 2024 ESC Guidelines for the management of ...

Jupiter Endovascular, Inc., announced recently that the FDA has approved the company’s application for an investigation ...

FlowPhysix Inc, formerly known as Expanse ICE, announced a strategic partnership with 3comma Medical/3comma Medical GmbH, whi ...

BioCardia, Inc. recently announced that the FDA has cleared the company’s Morph DNA steerable introducer product family ...

Laminate Medical Technologies announced that the United States Centers for Medicare & Medicaid Services (CMS) granted the ...

The European Society for Vascular Surgery recently announced the launch of the European Venous Registry (EVeR), which aims to ...

VVT Medical announced that the American Venous Forum (AVF) has provided an official opinion letter regarding CPT coding ...

Koya Medical announced the publication of full results from the TEAYS clinical study evaluating treatment effectiveness and ...

AngioDynamics, Inc. announced European CE Mark approval of the Auryon atherectomy system for the treatment of peripheral ...

Venova Medical, Inc. announced the initial closing of a $30 million Series B funding round. The privately held company is ...

Vesalio announced the United States commercialization of pVasc thrombectomy system for nonsurgically removing peripheral ...